Losartan Potassium And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72789-162

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Losartan Potassium And Hydrochlorothiazide (NDC 72789-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure1 (Structure 1)

Chemical structure of losartan potassium, one of the active ingredients in Losartan Potassium and Hydrochlorothiazide tablets. The structure includes characteristic ring systems and a potassium ion (K+).*

FDA Label Image

Structure2 (Structure 2)

Chemical structure of losartan potassium and hydrochlorothiazide, showing the molecular framework with sulfonamide, chloride, and nitrogen-containing rings as part of the compound's core.*

FDA Label Image

72789162 Label (72789162)

Packaging label for Losartan Potassium and Hydrochlorothiazide tablets, 50 mg/12.5 mg strength. The label indicates a count of 30 film-coated tablets. The labeler is PD-Rx Pharmaceuticals, Inc., located in Oklahoma City, OK. The label includes dosage form details, lot number F22E42, expiration date 02/2024, and handling warnings such as keeping out of reach of children and discontinuing use when pregnancy is detected.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.